Vaccines for the New Millennium Act of 2001
Latest action · Apr 25, 2001 Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 4, 2001
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Allows a limited lifesaving vaccine sale credit equal to the amount of qualified vaccine sales. Defines qualified vaccine sales as the aggregate amount paid to the taxpayer for a qualified sale. Defines a qualified sale as a sale of a qualified vaccine: (1) to a nonprofit organization or to a government of any foreign country (or instrumentality of such a government); and (2) for distribution in a developing country.
Establishes the Lifesaving Vaccine Purchase Fund.
Expresses the sense of Congress concerning the manufacture, distribution, support for global efforts, and tiered pricing of vaccines.
Cosponsors 25
Members who signed on, in the order they did. Signatures ran from Apr 4, 2001 to Oct 31, 2001; 21 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MD | Albert Russell Wynn | Original | Apr 4, 2001 |
| D-CA | Bob Filner | Original | Apr 4, 2001 |
| D-NY | Charles B. Rangel | Original | Apr 4, 2001 |
| R-MD | Constance A. Morella | Original | Apr 4, 2001 |
| D-VI | Donna M. Christensen | Original | Apr 4, 2001 |
| D-NY | Edolphus Towns | Original | Apr 4, 2001 |
| R-WA | Jennifer Dunn | Original | Apr 4, 2001 |
| D-WA | Jim McDermott | Original | Apr 4, 2001 |
| D-GA | John Lewis | Original | Apr 4, 2001 |
| D-NY | Jose E. Serrano | Original | Apr 4, 2001 |
| D-CA | Juanita Millender-McDonald | Original | Apr 4, 2001 |
| D-FL | Karen L. Thurman | Original | Apr 4, 2001 |
| D-CA | Lucille Roybal-Allard | Original | Apr 4, 2001 |
| D-CA | Lynn C. Woolsey | Original | Apr 4, 2001 |
| R-FL | Mark Foley | Original | Apr 4, 2001 |
| D-NY | Michael R. McNulty | Original | Apr 4, 2001 |
| D-FL | Peter Deutsch | Original | Apr 4, 2001 |
| R-PA | Phil English | Original | Apr 4, 2001 |
| D-CT | Rosa L. DeLauro | Original | Apr 4, 2001 |
| D-CA | Tom Lantos | Original | Apr 4, 2001 |
| D-LA | William J. Jefferson | Original | Apr 4, 2001 |
| D-CA | Ellen O. Tauscher | May 17, 2001 | |
| R-IL | Mark Kirk | May 17, 2001 | |
| D-TX | Martin Frost | May 17, 2001 | |
| D-MI | David E. Bonior | Oct 31, 2001 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Ways and Means Committee | Referred Apr 4, 2001 |
| House | Energy and Commerce Committee | Referred Apr 4, 2001 |
| Health Subcommittee | Referred Apr 25, 2001 | |
| House | Foreign Affairs Committee | Referred Apr 4, 2001 |
Actions 4
Everything that happened, newest first.
- Apr 25, 2001Referred to the Subcommittee on Health, for a period to be subsequently determined by the Chairman.
- Apr 5, 2001Sponsor introductory remarks on measure. (CR E554)
- Apr 4, 2001Introduced in House
- Apr 4, 2001Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and International Relations, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Internal Revenue Code of 1986 to allow a credit against income tax for research related to developing vaccines against widespread diseases and ensure that such vaccines are affordable and widely distributed.
- Short Titles as Introduced
- Vaccines for the New Millennium Act of 2001
Subjects
Assigned by the Library of Congress. Policy area: Taxation.
- AIDS (Disease)
- Biotechnology
- Business income tax
- Clinical trials
- Commerce
- Communicable diseases
- Developing countries
- Drug industry
- Economics and Public Finance
- Government trust funds
- Health
- Human immunodeficiency viruses
- Income tax
- International Affairs
- International agencies
- International cooperation
- Malaria
- Medical research
- Microbiological research
- Nonprofit organizations
- Pharmaceutical research
- Research and development tax credit
- Science, Technology, Communications
- Social Welfare
- Taxation
- Tuberculosis
- Vaccines
- World health
Text 1
Each version as it was printed, newest first.
- Apr 4, 2001Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
